CLOV vs. PAYO
CLOV (Clover Health Investments, Corp.) and PAYO (Payoneer Global Inc.) are both stocks. CLOV operates in Healthcare Plans (Healthcare), while PAYO operates in Software - Infrastructure (Technology). Over the past 3 years, CLOV returned 66.22%/yr vs 13.31%/yr for PAYO. At a 0.37 correlation, their price movements are largely independent.
Performance
CLOV vs. PAYO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLOV achieves a 101.28% return, which is significantly higher than PAYO's 20.11% return.
CLOV
- 1D
- -3.47%
- 1M
- 33.24%
- YTD
- 101.28%
- 6M
- 75.19%
- 1Y
- 61.43%
- 3Y*
- 66.22%
- 5Y*
- -20.64%
- 10Y*
- —
PAYO
- 1D
- 0.00%
- 1M
- 36.92%
- YTD
- 20.11%
- 6M
- 13.26%
- 1Y
- -2.17%
- 3Y*
- 13.31%
- 5Y*
- —
- 10Y*
- —
CLOV vs. PAYO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 101.28% | -25.40% | 230.85% | 2.43% | -75.01% | -71.32% |
PAYO Payoneer Global Inc. | 20.11% | -44.02% | 92.71% | -4.75% | -25.58% | -34.08% |
Correlation
The correlation between CLOV and PAYO is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2021 | 0.37 |
The correlation between CLOV and PAYO shifts across timeframes, from 0.26 (3 years) to 0.37 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CLOV:
$2.47B
PAYO:
$2.37B
CLOV:
-$0.11
PAYO:
$0.20
CLOV:
1.10
PAYO:
2.33
CLOV:
7.28
PAYO:
3.59
CLOV:
$2.21B
PAYO:
$1.07B
CLOV:
$939.14M
PAYO:
$660.73M
CLOV:
-$55.21M
PAYO:
$204.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLOV vs. PAYO — Risk / Return Rank
CLOV
PAYO
CLOV vs. PAYO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Payoneer Global Inc. (PAYO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLOV | PAYO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.91 | ||
| Sortino ratioReturn per unit of downside risk | +1.28 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.04 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.11 | -0.05 | +1.16 |
| Martin ratioReturn relative to average drawdown | 2.02 | -0.09 | +2.11 |
Loading charts...
Drawdowns
CLOV vs. PAYO - Drawdown Comparison
The maximum CLOV drawdown since its inception was -97.19%, which is greater than PAYO's maximum drawdown of -69.06%. Use the drawdown chart below to compare losses from any high point for CLOV and PAYO.
Loading charts...
Drawdown Indicators
| CLOV | PAYO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.19% | -69.06% | -28.13% |
Max Drawdown (1Y)Largest decline over 1 year | -55.50% | -42.45% | -13.05% |
Max Drawdown (3Y)Largest decline over 3 years | -64.73% | -61.36% | -3.37% |
Max Drawdown (5Y)Largest decline over 5 years | -95.76% | — | — |
Current DrawdownCurrent decline from peak | -78.65% | -39.46% | -39.19% |
Average DrawdownAverage peak-to-trough decline | -76.59% | -43.06% | -33.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.46% | 23.76% | +6.70% |
Volatility
CLOV vs. PAYO - Volatility Comparison
Clover Health Investments, Corp. (CLOV) has a higher volatility of 26.03% compared to Payoneer Global Inc. (PAYO) at 24.55%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than PAYO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLOV | PAYO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.03% | 24.55% | +1.48% |
Volatility (6M)Calculated over the trailing 6-month period | 43.15% | 43.67% | -0.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.33% | 53.15% | +18.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.38% | 56.64% | +20.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.80% | 56.64% | +29.16% |
Dividends
CLOV vs. PAYO - Dividend Comparison
Neither CLOV nor PAYO has paid dividends to shareholders.
Financials
CLOV vs. PAYO - Financials Comparison
This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Payoneer Global Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLOV vs. PAYO - Profitability Comparison
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.
PAYO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Payoneer Global Inc. reported a gross profit of 0.00 and revenue of 261.60M. Therefore, the gross margin over that period was 0.0%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.
PAYO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Payoneer Global Inc. reported an operating income of 30.02M and revenue of 261.60M, resulting in an operating margin of 11.5%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.
PAYO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Payoneer Global Inc. reported a net income of 19.57M and revenue of 261.60M, resulting in a net margin of 7.5%.
Frequently Asked Questions
CLOV and PAYO have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLOV has higher volatility (26.03%) compared to PAYO (24.55%). In terms of maximum drawdown, CLOV dropped -97.19% vs PAYO's -69.06%.
CLOV currently has the higher Sharpe Ratio (0.87 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLOV and PAYO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer